Suzhou Tianwo Science and Technology Co Ltd (002564) - Net Assets
Based on the latest financial reports, Suzhou Tianwo Science and Technology Co Ltd (002564) has net assets worth CN¥441.07 Million CNY (≈ $64.54 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.70 Billion ≈ $834.75 Million USD) and total liabilities (CN¥5.26 Billion ≈ $770.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 002564 financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥441.07 Million |
| % of Total Assets | 7.73% |
| Annual Growth Rate | 10.32% |
| 5-Year Change | -80.29% |
| 10-Year Change | -84.14% |
| Growth Volatility | 91.01 |
Suzhou Tianwo Science and Technology Co Ltd - Net Assets Trend (2007–2025)
This chart illustrates how Suzhou Tianwo Science and Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore how large is Suzhou Tianwo Science and Technology Co 's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Suzhou Tianwo Science and Technology Co Ltd (2007–2025)
The table below shows the annual net assets of Suzhou Tianwo Science and Technology Co Ltd from 2007 to 2025. For live valuation and market cap data, see how much is Suzhou Tianwo Science and Technology Co worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥441.07 Million ≈ $64.54 Million |
+19.71% |
| 2024-12-31 | CN¥368.45 Million ≈ $53.92 Million |
+7.71% |
| 2023-12-31 | CN¥342.09 Million ≈ $50.06 Million |
+115.88% |
| 2022-12-31 | CN¥-2.15 Billion ≈ $-315.31 Million |
-196.31% |
| 2021-12-31 | CN¥2.24 Billion ≈ $327.38 Million |
-27.51% |
| 2020-12-31 | CN¥3.09 Billion ≈ $451.65 Million |
-31.40% |
| 2019-12-31 | CN¥4.50 Billion ≈ $658.34 Million |
+3.25% |
| 2018-12-31 | CN¥4.36 Billion ≈ $637.61 Million |
+37.90% |
| 2017-12-31 | CN¥3.16 Billion ≈ $462.38 Million |
+13.64% |
| 2016-12-31 | CN¥2.78 Billion ≈ $406.89 Million |
-4.87% |
| 2015-12-31 | CN¥2.92 Billion ≈ $427.74 Million |
-0.76% |
| 2014-12-31 | CN¥2.95 Billion ≈ $431.02 Million |
+3.66% |
| 2013-12-31 | CN¥2.84 Billion ≈ $415.81 Million |
+31.67% |
| 2012-12-31 | CN¥2.16 Billion ≈ $315.80 Million |
+5.42% |
| 2011-12-31 | CN¥2.05 Billion ≈ $299.57 Million |
+251.94% |
| 2010-12-31 | CN¥581.70 Million ≈ $85.12 Million |
+26.72% |
| 2009-12-31 | CN¥459.06 Million ≈ $67.17 Million |
+166.84% |
| 2008-12-31 | CN¥172.03 Million ≈ $25.17 Million |
+128.62% |
| 2007-12-31 | CN¥75.25 Million ≈ $11.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Suzhou Tianwo Science and Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7983.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥858.90 Million | 461.34% |
| Other Comprehensive Income | CN¥82.69 Million | 44.42% |
| Other Components | CN¥3.19 Billion | 1714.33% |
| Total Equity | CN¥186.18 Million | 100.00% |
Suzhou Tianwo Science and Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Suzhou Tianwo Science and Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MedCap AB (publ)
ST:MCAP
|
$775.50 Million |
|
Zhongzhu Medical Holdings Co Ltd
SHG:600568
|
$775.71 Million |
|
MIPS AB
ST:MIPS
|
$776.01 Million |
|
Feitian Technologies Co Ltd
SHE:300386
|
$776.29 Million |
|
MBK Public Company Limited
BK:MBK-R
|
$775.40 Million |
|
Grendene S.A
SA:GRND3
|
$775.35 Million |
|
Karnov Group AB
ST:KAR
|
$775.03 Million |
|
Zhejiang Starry Pharm Co Ltd
SHG:603520
|
$774.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Suzhou Tianwo Science and Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 138,218,505 to 186,175,976, a change of 47,957,471 (34.7%).
- Net income of 46,974,012 contributed positively to equity growth.
- Dividend payments of 96,353,695 reduced retained earnings.
- Other comprehensive income increased equity by 983,458.
- Other factors increased equity by 96,353,696.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥46.97 Million | +25.23% |
| Dividends Paid | CN¥96.35 Million | -51.75% |
| Other Comprehensive Income | CN¥983.46K | +0.53% |
| Other Changes | CN¥96.35 Million | +51.75% |
| Total Change | CN¥- | 34.70% |
Book Value vs Market Value Analysis
This analysis compares Suzhou Tianwo Science and Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 28.46x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 30.66x to 28.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.20 | CN¥6.17 | x |
| 2008-12-31 | CN¥0.47 | CN¥6.17 | x |
| 2009-12-31 | CN¥1.14 | CN¥6.17 | x |
| 2010-12-31 | CN¥1.28 | CN¥6.17 | x |
| 2011-12-31 | CN¥3.47 | CN¥6.17 | x |
| 2012-12-31 | CN¥3.56 | CN¥6.17 | x |
| 2013-12-31 | CN¥4.29 | CN¥6.17 | x |
| 2014-12-31 | CN¥3.71 | CN¥6.17 | x |
| 2015-12-31 | CN¥4.08 | CN¥6.17 | x |
| 2016-12-31 | CN¥3.40 | CN¥6.17 | x |
| 2017-12-31 | CN¥3.61 | CN¥6.17 | x |
| 2018-12-31 | CN¥4.58 | CN¥6.17 | x |
| 2019-12-31 | CN¥4.29 | CN¥6.17 | x |
| 2020-12-31 | CN¥2.93 | CN¥6.17 | x |
| 2021-12-31 | CN¥2.12 | CN¥6.17 | x |
| 2022-12-31 | CN¥-2.49 | CN¥6.17 | x |
| 2023-12-31 | CN¥0.13 | CN¥6.17 | x |
| 2024-12-31 | CN¥0.17 | CN¥6.17 | x |
| 2025-12-31 | CN¥0.22 | CN¥6.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Suzhou Tianwo Science and Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.23%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.85%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 30.64x
- Recent ROE (25.23%) is below the historical average (62.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 55.90% | 7.12% | 0.74x | 10.68x | CN¥34.54 Million |
| 2008 | 56.26% | 11.00% | 0.66x | 7.80x | CN¥79.58 Million |
| 2009 | 26.21% | 13.15% | 0.40x | 4.95x | CN¥74.41 Million |
| 2010 | 23.52% | 13.01% | 0.39x | 4.61x | CN¥78.66 Million |
| 2011 | 7.06% | 9.79% | 0.36x | 2.02x | CN¥-60.15 Million |
| 2012 | 5.19% | 6.23% | 0.34x | 2.43x | CN¥-103.39 Million |
| 2013 | 4.43% | 6.06% | 0.35x | 2.11x | CN¥-157.82 Million |
| 2014 | 2.43% | 3.01% | 0.34x | 2.38x | CN¥-218.84 Million |
| 2015 | 0.98% | 1.23% | 0.33x | 2.39x | CN¥-259.28 Million |
| 2016 | -12.06% | -25.08% | 0.07x | 6.84x | CN¥-548.26 Million |
| 2017 | 8.30% | 2.16% | 0.46x | 8.33x | CN¥-46.06 Million |
| 2018 | 1.96% | 0.97% | 0.30x | 6.81x | CN¥-305.14 Million |
| 2019 | 1.16% | 0.39% | 0.34x | 8.67x | CN¥-324.53 Million |
| 2020 | -46.32% | -15.03% | 0.25x | 12.14x | CN¥-1.41 Billion |
| 2021 | -38.30% | -10.19% | 0.24x | 15.73x | CN¥-874.35 Million |
| 2022 | 0.00% | -71.87% | 0.15x | 0.00x | CN¥-2.37 Billion |
| 2023 | 1048.63% | 31.78% | 0.54x | 60.88x | CN¥1.19 Billion |
| 2024 | 17.39% | 0.98% | 0.41x | 43.36x | CN¥10.22 Million |
| 2025 | 25.23% | 1.85% | 0.44x | 30.64x | CN¥28.36 Million |
Industry Comparison
This section compares Suzhou Tianwo Science and Technology Co Ltd's net assets metrics with peer companies in the Specialty Industrial Machinery industry.
Industry Context
- Industry: Specialty Industrial Machinery
- Average net assets among peers: $2,004,947,424
- Average return on equity (ROE) among peers: -24.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Suzhou Tianwo Science and Technology Co Ltd (002564) | CN¥441.07 Million | 55.90% | 11.93x | $775.47 Million |
| Huayi Compressor Co Ltd (000404) | $4.89 Billion | 8.55% | 1.57x | $843.29 Million |
| Shenyang Machine Tool Co Ltd (000410) | $824.03 Million | -170.30% | 29.09x | $2.39 Billion |
| North Industries Group Red Arrow Co Ltd (000519) | $319.51 Million | 4.81% | 0.48x | $3.61 Billion |
| Bingshan Refrigeration & Heat Transfer Technologies Co Ltd (000530) | $3.45 Billion | 2.58% | 0.60x | $520.37 Million |
| Changchai Co Ltd (000570) | $3.36 Billion | 2.28% | 0.55x | $522.04 Million |
| Jiangsu Youli Investment Holding Co Ltd (000584) | $327.45 Million | -65.69% | 8.93x | $32.29 Million |
| Baota Industry Co Ltd (000595) | $746.32 Million | -18.39% | 0.62x | $1.06 Billion |
| SUFA Technology Industry Co Ltd CNNC (000777) | $280.92 Million | 8.98% | 0.50x | $1.11 Billion |
| J.S. Corrugating Machinery Co Ltd (000821) | $2.30 Billion | -22.46% | 1.14x | $938.81 Million |
| Qinchuan Machine Tool & Tool Group Share Co Ltd (000837) | $3.55 Billion | 0.54% | 0.80x | $1.66 Billion |
About Suzhou Tianwo Science and Technology Co Ltd
SuZhou THVOW Technology. Co., Ltd., together with its subsidiaries, manufactures and sells high-end equipment in China and internationally. The company offers pressure vessel, other special equipment, and marine equipment. It also engages in national defense construction, and power design and system solution businesses. In addition, the company provides warehousing and logistics; and power engine… Read more